Sunday, November 8, 2026

GBP/EUR Rises By 1% In The Last 21 Sessions

GBP/EUR Rises By 1% In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.85% for the last 21 sessions. At 15:08 EST on Sunday, 4 June, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 7.482% up from its 52-week low and 3.061% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was 0.27%, 0.13%, and 0.25%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.27% (last week), 0.24% (last month), and 0.25% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: euro bulls need validation from 100-day EMA and US NFP. According to FXStreet on Friday, 2 June, "That said, the Euro pair's successful break of a one-month-old descending trend line joins the receding bearish bias of the MACD indicator to keep the EUR/USD bulls hopeful in crossing the immediate hurdle comprising the 100-day Exponential Moving Average (EMA) of near 1.0775.", "On the flip side, a convergence of the previous resistance line and the 200-day EMA, around 1.0690-85, restrict immediate declines of the EUR/USD pair ahead of the previously mentioned rising support line from October 2022, close to 1.0635 at the latest."
  • Eur/usd could press the 1.0810/20 area if NFP does not come in too hot – ING. According to FXStreet on Friday, 2 June, "Economists at ING analyze EUR/USD outlook ahead of the US Nonfarm Payrolls report.", "Today's US data will have a big say in determining whether this week's EUR/USD low of 1.0635 was significant."
  • Eur/usd: ECB monetary policy is not going to provide any further upside potential for the euro – commerzbank. According to FXStreet on Friday, 2 June, "Economists at Commerzbank discuss ECB policy outlook and its implications for the EUR/USD pair.", "A return to higher EUR/USD levels would have to be driven by a more cautious outlook for Fed interest rates."
  • Eur/usd stumbles on solid US NFP data, traders bet for a July fed hike. According to FXStreet on Friday, 2 June, "At the time of writing, the EUR/USD is trading at 1.0715, printing losses of 0.43%.", "Since the data release, the EUR/USD pair lost 40 pips or 0.40% intraday, threatening to get toward the 1.0700 figure as the greenback limps its wounds. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com